Clinical Trials Directory

Trials / Completed

CompletedNCT01211769

Effects of Omegas 3 and 6 on Alcohol Dependence

Alcohol Dependence: Study of the Possible Reduction of Compulsion by Association of Naltrexone With Poly-unsaturated Fatty Acids (PUFAs)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Federal University of São Paulo · Academic / Other
Sex
Male
Age
30 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Context: The treatment of alcoholism is a challenge for psychiatrists and patients. Some studies have shown that alcohol alters the environment of the membranes, mainly by modifying their permeability through the lipid fraction. These lipids are known as essential fatty acids (EFA) because they are obtained only through the diet, as the human body is unable to synthesize them. Linolenic acid (LA), or omega 6, and alpha-linolenic acid (ALA), or omega 3, are polyunsaturated fatty acids (PUFAs). Finally, ethanol changes the absorption and metabolism of PUFAs, and it's supplementation may be helpful for alcohol dependence recovery. Objective: to assess the effectiveness of PUFAs supplementation in the treatment of alcohol dependent patients.

Conditions

Interventions

TypeNameDescription
DRUGNaltrexoneA pill of naltrexone chlorhydrate 50mg, associated to yellow liquid paraffin pills simulating borage seed and fish oil.
DRUGPUFAsBorage Oil (Borago officinalis L. Boraginaceae) - rich in omega 6 PUFA, dosage of 1 gram and Fish oil 1 gram - rich in omega 3 PUFAs; associated to a pill with 50mg of talcum powder, identical to the pill of naltrexone.
DRUGPlaceboA pill with 50mg of talcum powder, identical to the pill of naltrexone; associated to PUFAs Placebo pills (yellow liquid paraffin identical to the pills of borage seed and fish oil).
DRUGNaltrexone + PlaceboA pill of naltrexone chlorhydrate 50mg, associated to Borage Oil (Borago officinalis L. Boraginaceae) - rich in omega 6 PUFA, dosage of 1 gram and Fish oil 1 gram - rich in omega 3 PUFAs.

Timeline

Start date
2006-02-01
Primary completion
2008-06-01
Completion
2008-06-01
First posted
2010-09-29
Last updated
2010-09-29
Results posted
2010-09-29

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01211769. Inclusion in this directory is not an endorsement.